| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer
2 companies
Kooij Louise Frederika is a Chief Accounting Officer at NewAmsterdam Pharma Co N.V. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | NAMSW Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sale+OE | 72,428 | $32.25 | $2,335,859.52 | -59.8% | -17.3% | - | |
| Jan 5, 2026 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sell | 2,647 | $33.25 | $88,012.75 | -17.6% | +1.9% | - | |
| Dec 26, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sale+OE | 145,000 | $35.84 | $5,196,740.65 | -76.3% | -11.4% | - | |
| Sep 9, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sale+OE | 150,000 | $25.83 | $3,874,016.80 | -54.2% | +34.4% | - | |
| Sep 3, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sell | 18,073 | $25.09 | $453,451.57 | -54.6% | +54.1% | - | |
| Aug 25, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sell | 8,269 | $24.86 | $205,567.34 | -35.5% | +59.1% | - | |
| Mar 4, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sale+OE | 150,000 | $20.37 | $3,055,500.00 | -90.9% | -12.0% | +45.0% | |
| Oct 1, 2024 | NAMS Newamsterdam Pharma Co N.V. | Chief Accounting Officer | Sale+OE | 45,000 | $15.72 | $707,400.00 | -100% | +48.1% | +69.8% |